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Exposure to air particulate matter has been linked with hypertension and blood pressure levels. The 
metabolic risks of air pollution could vary according to the specific characteristics of each area, and 
has not been sufficiently evaluated in Spain. We analyzed 1103 individuals, participants in a Spanish 
nationwide population based cohort study (di@bet.es), who were free of hypertension at baseline 
(2008–2010) and completed a follow‑up exam of the cohort (2016–2017). Cohort participants were 
assigned air pollution concentrations for particulate matter < 10 μm  (PM10) and < 2.5 μm  (PM2.5) during 
follow‑up (2008–2016) obtained through modeling combined with measurements taken at air quality 
stations (CHIMERE chemistry‑transport model). Mean and SD concentrations of  PM10 and  PM2.5 
were 20.17 ± 3.91 μg/m3 and 10.83 ± 2.08 μg/m3 respectively. During follow‑up 282 cases of incident 
hypertension were recorded. In the fully adjusted model, compared with the lowest quartile of  PM10, 
the multivariate weighted ORs (95% CIs) for developing hypertension with increasing  PM10 exposures 
were 0.82 (0.59–1.14), 1.28 (0.93–1.78) and 1.45 (1.05–2.01) in quartile 2, 3 and 4 respectively (p for a 
trend of 0.003). The corresponding weighted ORs according to  PM2.5 exposures were 0.80 (0.57–1.13), 
1.11 (0.80–1.53) and 1.48 (1.09–2.00) (p for trend 0.004). For each 5‑μg/m3 increment in  PM10 and  PM2.5 
concentrations, the odds for incident hypertension increased 1.22 (1.06–1.41) p = 0.007 and 1.39 (1.07–
1.81) p = 0.02 respectively. In conclusion, our study contributes to assessing the impact of particulate 
pollution on the incidence of hypertension in Spain, reinforcing the need for improving air quality as 
much as possible in order to decrease the risk of cardiometabolic disease in the population.
The World Health Organization (WHO) has identified air pollution as the largest single environmental health risk 
worldwide with outdoor air pollution accounting for more than 4.2 million deaths every  year1. Particulate matter 
(PM) is a widespread air pollutant, consisting of a complex mixture of particles of different sizes and chemistry 
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which are suspended in the air emitted from a range of sources. Particles with an aerodynamic diameter of less 
than 10 µm  (PM10) include those inhalable particles that are sufficiently small to penetrate the respiratory tract. 
The fine fraction of  PM10 includes particles with an aerodynamic diameter of less than 2.5 µm  (PM2.5) which 
have a high probability of deposition in the smaller airways and alveoli. Chronic exposure to PM contributes 
to the risk of cardiovascular and respiratory  diseases1,2. Particulate air pollution can impact the cardiovascular 
system through a number of mechanisms including endothelial dysfunction, systemic and pulmonary oxidative 
stress and inflammation, autonomic nervous system dysfunction and epigenetic  changes3–6. Hypertension, as 
one of the most important risk factors for cardiovascular  disease7, could also be a main mediator. Accordingly, 
a number of experimental and epidemiological studies have described the relationship of both short-term and 
long-term exposure to ambient air pollutants with hypertension and blood pressure (BP)  levels8. However, 
relatively fewer studies have investigated the association between long-term exposure to PM and the incidence 
of hypertension  prospectively9–16. It is noteworthy that air pollution effects could vary according to the specific 
air pollution mix of each area, climatic features, the genetic background, as well as the underlying lifestyle and 
health characteristics of the studied  population17. In this regard, previous evidence in the Spanish population 
has been scarce, and limited to local  studies12,18. The di@bet.es study provides us with the opportunity to study 
this phenomenon, from a nationwide population-based study perspective.
Results
Study sample. The study population was composed of 1103 subjects, without hypertension at baseline, fol-
lowed up for a mean of 7.4 years (5.8–8.8 years). The baseline characteristics of the study sample are presented 
in Table 1. Mean age ranged from 18 to 83 years, the percentage of women was 63.4%. Most of the population 
was Caucasian. The education level, proportion of smokers, drinking behavior, adherence to Mediterranean 
diet, physical activity and BMI are within the expected range according to the background population. Mean 
annual ambient temperature ranged between 9.9 and 18.8 °C, whereas mean ambient humidity was between 
57 and 79%. A comparison of included and excluded individuals based on these covariates is included in Sup-
plementary Table S1. Residential estimates of outdoor air pollution concentrations during follow-up across the 
study sample were relatively low, with mean and SD concentrations of  PM10 and  PM2.5 of 20.17 ± 3.91 μg/m3 
and 10.83 ± 2.08 μg/m3 respectively (Table 2), again concordant with the background estimates for the Spanish 
population.
Incidence of hypertension according to  PM10 and  PM2.5 concentrations. During follow-up, 282 
cases of incident hypertension were recorded (25.6% of the study sample). Table 3 shows the incidence rates, 
and crude and multivariate weighted ORs and 95% CIs for developing hypertension according to  PM10 and 
 PM2.5 concentration quartiles. As can be observed, both higher  PM10 and  PM2.5 concentrations were significantly 
associated with increased ORs of incident hypertension with a significant dose response. Multivariate weighted 
analysis of the data even strengthened the association. In the fully adjusted model, the highest  PM10 exposure 
Table 1.  Baseline characteristics of the study population (1103 individuals without HT at baseline).
% Mean ± SD Range

















BMI (kg/m2) 26.7 ± 4.2 16.7–49.4
Systolic BP (mmHg) 119.5 ± 11.3 89.5–139.7
Diastolic BP (mmHg) 72.1 ± 7.8 47.5–89.7
Mean ambient temperature (°C) 15.2 ± 2.3 9.9–18.8
Relative humidity (%) 63.5 ± 5.3 57–79
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quartile  (PM10 22.80–30.18 μg/m3) was associated with a significant OR for developing hypertension of 1.45 
(95% CIs 1.05–2.01), compared with the reference category. Accordingly, the highest  PM2.5 exposure quartile 
(11.80–16.49 μg/m3) was associated with a significant OR for incident hypertension of 1.48 (95% CIs 1.09–2.00). 
For each 5-μg/m3 increment in  PM10 and  PM2.5 concentrations the odds for incident hypertension were 1.22 
(1.06–1.41) p = 0.007 and 1.39 (1.07–1.81) p = 0.02 respectively.
Subgroup analysis. Subgroup analysis showed that the association was consistent across strata of sex, age, 
MedScore adherence, physical activity, smoking status, alcohol intake and BMI without any significant effect 
modification by these factors (Fig. 1).
Discussion
In this nationwide cohort of Spanish non-hypertensive adults we found a positive association between PM con-
centrations (both  PM10 and  PM2.5) and the incidence of hypertension after a mean follow-up of 7.4 years. The 
association remained after multivariate weighted analysis of the data, showing a significant dose response, and 
was consistent across various subgroups.
To the best of our knowledge, this report provides the first data about the impact of air pollutants on hyper-
tension in Spain from a National study perspective, whereas previous evidence had been limited to local studies 
from Northeast  Spain18, also included in multicenter  studies12.
Our data are consistent with a large body of evidence suggesting that air pollution may contribute to hyper-
tension  pathogenesis8, also supporting that the particulate component of air pollution is the most important 
threat for the cardiovascular  system3–6. In this regard, although previous associations between exposure to 
gaseous pollutants and hypertension have shown some discrepancies, the majority of the studies reporting on 
long-term exposure to PM and incident hypertension have reported positive associations which are consistent 
with our  findings9–16.
Interestingly, these associations have now been observed in studies from countries with relatively low con-
centrations of PM from North America (mean  PM2.5 of 10.7 μg/m310, 13.9 μg/m311 and 13.2 μg/m313 and Europe, 
(mean  PM2.5 between 6.6 and 15 μg/m312 and 10.8 μg/m3 in in the present study), and also at highly polluted 
Table 2.  Descriptive statistics for  PM10 (μg/m3) and  PM2.5 (μg/m3) during follow-up (2008–2016) in the 
study cohort. PM10, particles with an aerodynamic diameter of less than 10 µm; PM2.5, particles with an 
aerodynamic diameter of less than 2.5 µm; SD, standard deviation.
Pollutant
Percentile
Mean SD Minimum Maximum5th 25th 50th 75th 95th
PM10 14.57 16.95 20.00 22.79 27.55 20.17 3.91 12.21 30.18
PM2.5 7.92 9.31 10.77 11.79 15.63 10.83 2.08 7.25 16.49
Table 3.  Incidence rates and crude and multivariate adjusted odd ratios for developing hypertension 
according to  PM10 and  PM2.5 concentrations during follow-up (2008–2016). CI, confidence Interval; HT, 
hypertension; IPAQ, international physical activity questionnaire; IPW, inverse probability weighting. 
MedScore, mediterranean diet score;  PM10, particles with an aerodynamic diameter of less than 10 µm;  PM2.5, 
particles with an aerodynamic diameter of less than 2.5 µm; OR, odds ratio. *Inverse probability weighting 
(IPW) using as confounding variables age, gender, ethnicity, education level, MedScore, IPAQ, alcohol intake, 
smoking, BMI, BP levels at baseline, Ambient temperature and Humidity.
PM 10 (μg/l) PM 10
12.21–16.95 16.96–20.00 20.01–22.79 22.80–30.18 p for trend Per 5-μg/m3 increment p
Number at risk 278 280 279 266

























PM 2.5 (μg/l) PM 2.5
7.25–9.31 9.32–10.77 10.78–11.79 11.80–16.49 p for trend
Per 5-μg/m3
increment p
Number at risk 280 275 279 269
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regions in Asia (mean  PM2.5 26.5 μg/m314, 77.7 μg/m315 and 92.1 μg/m316. This strongly suggests that the relation 
between PM exposures and hypertension development is likely a general phenomenon across different popula-
tions and over the pollution range. In fact, the increased incidence of hypertension we describe in our study 
occurs within  PM10 and  PM2.5 concentration ranges which are well below the existing European Ambient Air 
Quality Directive target values (PM10 < 40 µg/m3 and PM2.5 < 25 µg/m3)19. In contrast, our results are in line 
and reinforce the validity of the maximum annual concentrations for health protection suggested by the WHO 
 (PM10 < 20 µg/m3and  PM2.5 < 10 µg/m3)20.
The mechanism by which PM could contribute to the development of hypertension includes inflammation 
and oxidative stress and the triggering of autonomic nervous system imbalance affecting vascular tone and 
 reactivity3. Epigenetic changes that occur during exposure may also play a role in the interaction between air 
pollution and  Hypertension21–23.
Interestingly, controlled studies in humans have confirmed observational results showing that acute inhalation 
of concentrated particulate matter can trigger a rapid and sustained increase in blood  pressure24.
Moreover, the use of air filtration to lower PM concentrations has demonstrated rapid effects in reducing 
blood pressure, further supporting this biological  relationship25–27.
Our study has several limitations:
Firstly, our sample size is relatively small, which can affect the precision of the estimates. Due to the experi-
mental design, the time from event until outcome was not available for analysis. We therefore used logistic 
regression models to calculate adjusted odds ratios, which are known to overestimate relative  risks28.
Secondly, our food frequency questionnaire did not include data on salt consumption of the participants so 
that we could not adjust our analyses accordingly.
Thirdly, nationwide Spanish noise maps are also not available at present, so we could not adjust our analyses 
by ambient noise. Nevertheless, although long‐term noise exposure has been linked to incident hypertension in 
some  studies12,29, the results have been  inconsistent30. Moreover the associations between PM and hypertension 
in both cross  sectional31–33, and longitudinal  studies9,12 have not changed substantially after adjustment for noise.
Finally, as in other studies, we used ambient outdoor measurements modeled at the residential addresses of 
the participants as a proxy for exposure to air pollution, whereas no information on time–activity patterns or 
on the PM concentrations indoors was available. This is however a common limitation to most studies assessing 
the health effects of air pollution and, in fact, air quality guidelines focus primarily on ambient (outdoor) air 
pollution for their  recommendations20.
As strengths of the study we included a population-based design with BP measurements of each participant 
at both baseline and follow-up examinations so we could identify both diagnosed and undiagnosed cases of 
hypertension.
We have also included extensive individual-level data including clinical, demographic and lifestyle variables 
which allowed us to perform a robust multivariate adjustment of the data.
Finally, our nationwide perspective, first in the Spanish population, allows us to extrapolate our results more 
widely than local or regional studies increasing the public health implications of the findings.
In conclusion, our study contributes to assessing the impact of particulate pollution on the incidence of 
hypertension in Spain. Our results reinforce the need for improving air quality as much as possible to decrease 
the risk of hypertension in our population, since even moderate levels such as those in this study raise the risk 
significantly.
Figure 1.  Association between  PM10 (1A) and  PM2.5 (1B) exposures and incident hypertension stratified by 
selected characteristics. Dots and bars are ORs and 95% CI for incident hypertension per 5 μg/m3 increment 
of PM concentrations of  PM10 (1A) and  PM2.5 (1B) and NO2 (3C) derived from multiple logistic regression 
analyses. BMI, body mass index; CI, confidence interval; IPAQ, international physical activity questionnaire; 
MedScore, mediterranean diet score; PM, particulate matter;  PM10, particles with an aerodynamic diameter of 
less than 10 µm;  PM2.5, particles with an aerodynamic diameter of less than 2.5 µm.
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Methods
Study design, setting and population. The di@bet.es epidemiological trial is a population based cohort 
study. The initial cross-sectional study was undertaken between 2008 and 2010 using a random cluster sampling 
to form a representative random sample of the Spanish  population34. The study sample consisted of 5072 subjects 
older than 18 years, randomly selected from the National Health System registries distributed into 110 clusters 
(primary health care centers).
The cohort was re-evaluated in 2016–17 (follow-up time was 7.4 ± 0.5 years).
For the present study, residents in the Canary Islands (no data on emissions available) and subjects who had 
hypertension or missing data on blood pressure at baseline were excluded from all the incidence calculations. 
Therefore, the at-risk sample included 2697 people who were residents in the Iberian Peninsula or the Balearic 
islands and without hypertension at baseline. Of this at-risk sample, 97 individuals had no contact information, 
62 individuals had died and 200 had moved from their original location before the follow-up started. 65 other 
individuals were excluded (because of pregnancy or recent delivery, severe disease, institutionalized, hospitali-
zation, or surgery during the previous month). Of the remaining 2273 individuals, 1103 subjects completed 
the follow-up, with complete clinical information and BP measurements available for analyses (Fig. 2). The 
research was carried out in accordance with the Code of Ethics of the World Medical Association (Declaration 
of Helsinki). Written informed consent was obtained from all the participants. The study was approved by the 
Ethics and Clinical Investigation Committee of the Hospital Regional Universitario de Málaga (Malaga, Spain) 
in addition to other regional ethics and clinical investigation committees all over Spain.
Variables and procedures. In both phases of the study, the participants were invited to attend an exami-
nation visit at their health center with a nurse specially trained for this project. Information was collected using 
an interviewer administered structured questionnaire, followed by a physical examination and blood sampling.
Information on age, gender, educational level, ethnicity, smoking status, alcohol intake and other socio-
demographic variables was obtained by questionnaire. Food consumption was determined by a food frequency 
questionnaire and adherence to the Mediterranean diet was estimated by an adaptation of a 14 item Mediter-
ranean diet score (MedScore)35 Supplementary Table S2. The level of daily physical activity was estimated by the 
short form of the International Physical Activity Questionnaire (IPAQ)36. Weight and height were measured by 
standardized methods. The BMI was calculated. Blood pressure was measured using a blood pressure monitor 
(Hem-703C, Omron, Barcelona, Spain) after several minutes in a sitting position; the mean of 3 measurements 
taken at least 2 min apart was used for analysis. In both phases of the study, hypertension was considered if there 
was a previously self-reported physician-diagnosed hypertension and/or if the mean systolic blood pressure 
was ≥ 140 mmHg and/or the mean diastolic blood pressure was ≥ 90  mmHg7.
The mean annual temperature (°C) and relative humidity (%) from each site was obtained from the Spanish 
National Meteorological Agency  website37.
Exposure assessment. Mean annual  PM2.5 and  PM10 concentrations in Spain for the period 2008–2016 
were calculated with the CHIMERE chemistry-transport  model38 This model calculates the concentration of 
gaseous species and both inorganic and organic aerosols of primary and secondary origin, including primary 
particulate matter, mineral dust, sulphate, nitrate, ammonium, secondary organic species and water. This model 
has been broadly evaluated in Spain by comparison with measured air pollutants at a large set of monitor-
ing  sites39,40. The model was applied to a domain covering the Iberian Peninsula at a horizontal resolution of 
0.1 × 0.1° (approximately 10 × 10  km2), except for 2015 and 2016, when a resolution of approximately 5 × 5  km2 
was used. The modeled concentrations were corrected with observed values, by considering a methodology 
Figure 2.  Participation flow chart.
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described by Martín et al.41 in which (1) a bias is calculated with respect to the observations in the Spanish air 
quality network of monitoring sites, (2) these biases are spatially interpolated using a krigging methodology to 
obtain a gridded bias, and (3) this gridded bias is applied to the modeled concentration grid. This methodology 
considers a different bias grid for rural and urban sites that are then combined and weighted by population den-
sity. This methodology is currently used to support the Spanish Ministry for Ecological Transition in the process 
of evaluation and information to the European Commission about the air quality in  Spain42.
We combined the mean annual averages from each follow up year into an 8 year moving average. We assigned 
the 8 year exposure average at each participant address by interpolating the estimated concentrations to the 
centroid of their residential postal codes. Figure 3 shows the modeled concentrations of  PM10 and  PM2.5 during 
the study period in Spain, and the location of study clusters where the crossing between participant addresses 
and PM exposure estimates was performed.
Statistical analysis. The study population was categorized into four groups according to the quartiles of 
the mean 8 year exposures of  PM10 and  PM2.5 during follow-up (2008–2016). Incidence rates of hypertension 
during follow-up were estimated on each quartile calculating the incidence rates for each 1000 inhabitant-years 
(95% confidence interval [CI]). We constructed logistic regression models to calculate the odds ratios for devel-
oping hypertension according to the  PM10 and  PM2.5 categories using the first exposure quartile as a reference. 
The association of each 5 μg/m3 increment of PM concentrations with incident hypertension was also calculated. 
To decrease the likelihood of bias we used an inverse probability weighting (IPW) approach by means of the 
propensity scores  method43, using as possible confounding variables age, gender, ethnicity (Caucasian/others), 
education level (no studies/basic/high school-college), MedScore, IPAQ (low/medium/high)36, alcohol intake 
(< 30/30–60/ > 60 servings per month), smoking (never-former/current), BMI, BP levels at baseline, ambient 
temperature and humidity. These variables are all accepted risk factors for hypertension.
In addition, we performed subgroup analyses to test potential effect modifications in the association between 
PM exposures and incident hypertension by sex (male/female), age (< 40/40–60 or ≥ 60 years), MedScore (< 8 
or ≥ 8), IPAQ (low, medium or high), smoking status (never-former or current), alcohol intake (< 30 or ≥ 30 per 
month) and BMI (< 30 or ≥ 30 kg/m2). Each potential modifier was examined in a separate model by adding an 
interaction term. We evaluated the significance of effect modification with the likelihood ratio test. Reported p 
values were based on two-sided tests with statistical significance set at 0.05.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on 
reasonable request.
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